litlas
ログインアカウント作成

Yong Song

1995–2026 年に発表

別表記
Yong-Song
381
論文数
20,465
被引用数
82
h 指数
271
i10 指数

被引用数

Yong Song の年別被引用数1964 年: 被引用 1 件1996 年: 被引用 3 件1997 年: 被引用 2 件1998 年: 被引用 10 件1999 年: 被引用 14 件2000 年: 被引用 20 件2001 年: 被引用 18 件2002 年: 被引用 33 件2003 年: 被引用 25 件2004 年: 被引用 32 件2005 年: 被引用 27 件2006 年: 被引用 35 件2007 年: 被引用 51 件2008 年: 被引用 35 件2009 年: 被引用 64 件2010 年: 被引用 58 件2011 年: 被引用 56 件2012 年: 被引用 73 件2013 年: 被引用 79 件2014 年: 被引用 126 件2015 年: 被引用 139 件2016 年: 被引用 167 件2017 年: 被引用 177 件2018 年: 被引用 169 件2019 年: 被引用 731 件2020 年: 被引用 838 件2021 年: 被引用 981 件2022 年: 被引用 891 件2023 年: 被引用 766 件2024 年: 被引用 1,142 件2025 年: 被引用 705 件2026 年: 被引用 60 件1965〜1995 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図中国: 引用元論文 3,347 件、この内訳の 34.4%アメリカ合衆国: 引用元論文 1,406 件、この内訳の 14.5%インド: 引用元論文 367 件、この内訳の 3.8%イギリス: 引用元論文 323 件、この内訳の 3.3%イタリア: 引用元論文 314 件、この内訳の 3.2%ドイツ: 引用元論文 293 件、この内訳の 3%カナダ: 引用元論文 234 件、この内訳の 2.4%日本: 引用元論文 222 件、この内訳の 2.3%オーストラリア: 引用元論文 206 件、この内訳の 2.1%フランス: 引用元論文 202 件、この内訳の 2.1%スペイン: 引用元論文 201 件、この内訳の 2.1%韓国: 引用元論文 190 件、この内訳の 2%
0%34.4%その他 24.8%

機関

分野

  • Medicine40.9%
  • Biochemistry, Genetics and Molecular Biology30.7%
  • Computer Science9.2%
  • Engineering8.3%
  • Immunology and Microbiology3.4%
  • Neuroscience1.5%
  • その他6%

トピック

  • Cancer-related molecular mechanisms research5%
  • Lung Cancer Treatments and Mutations4.3%
  • Cancer Immunotherapy and Biomarkers3.7%
  • Lung Cancer Research Studies2.8%
  • RNA modifications and cancer2.6%
  • Circular RNAs in diseases2.3%
  • その他79.3%

共著者

全論文

検索で開く
  1. A deep learning algorithm for detection of oral cavity squamous cell carcinoma from photographic images: A retrospective study

    著者: Qiuyun Fu, Yehansen Chen, Zhihang Li, Qianyan Jing, Chuanyu Hu, Han Liu, Jiahao Bao, Yuming Hong, Ting Shi, LI Kai-xiong, Haixiao Zou, Yong Song, Hengkun Wang, Xiqian Wang, Yufan Wang, Jianying Liu, Hui Liu, Sulin Chen, Ruibin Chen, Man Zhang, Jingjing Zhao, Junbo Xiang, Bing Liu, Jun Jia, Hanjiang Wu, Yifang Zhao, Lin Wan, Xuepeng Xiong - EClinicalMedicine 2020 被引用: 244

  2. Efficacy and Safety of Sintilimab Plus Pemetrexed and Platinum as First-Line Treatment for Locally Advanced or Metastatic Nonsquamous NSCLC: a Randomized, Double-Blind, Phase 3 Study (Oncology pRogram by InnovENT anti-PD-1-11)

    著者: Yunpeng Yang, Zhehai Wang, Jian Fang, Qitao Yu, Baohui Han, Shundong Cang, Gongyan Chen, Xiaodong Mei, Zhixiong Yang, Rui Ma, Minghong Bi, Xiubao Ren, Jianying Zhou, Baolan Li, Yong Song, Jifeng Feng, Juan Li, Zhiyong He, Rui Zhou, Weimin Li, You Lü, Yingyi Wang, Lijun Wang, Nong Yang, Yan Zhang, Zhuang Yu, Yanqiu Zhao, Conghua Xie, Ying Cheng, Hui Zhou, Shuyan Wang, Donglei Zhu, Wen Zhang, Li Zhang - Journal of Thoracic Oncology 2020 被引用: 396

  3. Toripalimab Plus Chemotherapy for Patients With Treatment-Naive Advanced Non–Small-Cell Lung Cancer: A Multicenter Randomized Phase III Trial (CHOICE-01)

    著者: Zhijie Wang, Lin Wu, Baolan Li, Ying Cheng, Xiaoling Li, Xicheng Wang, Liang Han, Xiaohong Wu, Yun Fan, Yan Yu, Dongqing Lv, Jianhua Shi, Jianjin Huang, Shaozhang Zhou, Baohui Han, Guogui Sun, Qisen Guo, Youxin Ji, Xiaoli Zhu, Sheng Hu, Wei Zhang, Qiming Wang, Yuming Jia, Ziping Wang, Yong Song, Jingxun Wu, Meiqi Shi, Xingya Li, Zhigang Han, Yunpeng Liu, Zhuang Yu, Anwen Liu, Xiuwen Wang, Caicun Zhou, Diansheng Zhong, Liyun Miao, Zhihong Zhang, Hui Zhao, Jiaqi Yang, Dong Wang, Yingyi Wang, Qiang Li, Xiaodong Zhang, Mei Ji, Zhenzhou Yang, Jiuwei Cui, Beili Gao, Buhai Wang, Hu Liu, Lei Nie, Mei He, Jin Shi, Wei Gu, Yongqian Shu, Tong Zhou, Jian Feng, Xinmei Yang, Cheng Huang, Bo Zhu, Yu Yao, Xiongwen Tang, Jianjun Yu, Ellen Maher, Hui Feng, Sheng Yao, Patricia Keegan, Jie Wang - Journal of Clinical Oncology 2022 被引用: 172

  4. Bevacizumab plus erlotinib in Chinese patients with untreated, EGFR-mutated, advanced NSCLC (ARTEMIS-CTONG1509): A multicenter phase 3 study

    著者: Qing Zhou, Chong‐Rui Xu, Ying Cheng, Yunpeng Liu, Gongyan Chen, Jiuwei Cui, Nong Yang, Yong Song, Xiaoling Li, Shun Lü, Jianying Zhou, Zhiyong Ma, Shiying Yu, Cheng Huang, Yongqian Shu, Zhen Wang, Jin‐Ji Yang, Hai‐Yan Tu, Wen‐Zhao Zhong, Yi‐Long Wu - Cancer Cell 2021 被引用: 228

  5. The Influence of the Activation Function in a Convolution Neural Network Model of Facial Expression Recognition

    著者: Yingying Wang, Yibin Li, Yong Song, Xuewen Rong - Applied Sciences 2020 被引用: 319

  6. Clinical significance of PD-L1 expression in serum-derived exosomes in NSCLC patients

    著者: Chuling Li, Chuwei Li, Chunchun Zhi, Wenjun Liang, Xuan Wang, Xi Chen, Tangfeng Lv, Qin Shen, Yong Song, Dang Lin, Hongbing Liu - Journal of Translational Medicine 2019 被引用: 231

  7. DGM-VINS: Visual-Inertial SLAM for Complex Dynamic Environments With Joint Geometry Feature Extraction and Multiple Object Tracking

    著者: Boyi Song, Xianfeng Yuan, Zhongmou Ying, Baojiang Yang, Yong Song, Fengyu Zhou - IEEE Transactions on Instrumentation and Measurement, IEEE Trans. Instrum. Meas. 2023 被引用: 53

  8. First-line icotinib versus cisplatin/pemetrexed plus pemetrexed maintenance therapy for patients with advancedEGFR mutation-positive lung adenocarcinoma (CONVINCE): a phase 3, open-label, randomized study

    著者: Yuankai Shi, L. Wang, Baohui Han, W. Li, Pei-wu Yu, Y.P. Liu, Chunming Ding, Xia Song, Z.Y. Ma, Xiaowen Ren, J. Feng, H. L. Zhang, G. -Y. Chen, Xiaohong Han, Ning Wu, Chia-Yu Yao, Yong Song, S. C. Zhang, Wei Song, X. Q. Liu, Sha Zhao, Yangxuan Lin, X.Q. Ye, K. Li, Yongqian Shu, Lili Ding, F. Tan, Yan Sun - Annals of Oncology 2017 被引用: 338

  9. Long non-coding RNAs: A new frontier in the study of human diseases

    著者: Xuefei Shi, Ming Sun, Hongbing Liu, Yanwen Yao, Yong Song - Cancer Letters 2013 被引用: 1,175

  10. Tumor‐derived exosomal lncRNA GAS5 as a biomarker for early‐stage non‐small‐cell lung cancer diagnosis

    著者: Chuling Li, Yanling Lv, Chenye Shao, Cen Chen, Tianli Zhang, Yuqing Wei, Hang Fan, Tangfeng Lv, Hongbin Liu, Yong Song - Journal of Cellular Physiology 2019 被引用: 178

  11. Consensus for HER2 alterations testing in non-small-cell lung cancer

    著者: Shengxiang Ren, Jiong Wang, Jianming Ying, Tetsuya Mitsudomi, Daniel Lee, Zengwu Wang, Q. Chu, Philip C. Mack, Ying Cheng, Jianchun Duan, Yun Fan, Baohui Han, Zhouguang Hui, A. Liu, Jing Liu, You Lü, Z. Ma, Meiqi Shi, Yongqian Shu, Qibin Song, Xia Song, Yong Song, C. Wang, X. Wang, Zhaoguang Wang, Yi Xu, Yu Yao, L. Zhang, Mingfang Zhao, Bo Zhu, Jun Zhang, Caicun Zhou, Fred R. Hirsch - ESMO Open 2022 被引用: 111

  12. Downregulation of GSDMD attenuates tumor proliferation via the intrinsic mitochondrial apoptotic pathway and inhibition of EGFR/Akt signaling and predicts a good prognosis in non‑small cell lung cancer

    著者: Jianwei Gao, Xiangyu Qiu, Guangmin Xi, Hongbing Liu, Fang Zhang, Tangfeng Lv, Yong Song - Oncology Reports 2018 被引用: 280

  13. Grey wolf optimizer with an enhanced hierarchy and its application to the wireless sensor network coverage optimization problem

    著者: Zhaoming Miao, Xianfeng Yuan, Fengyu Zhou, Xuanjie Qiu, Yong Song, Ke Chen - Applied Soft Computing, Appl. Soft Comput. 2020 被引用: 97

  14. Targeting the ubiquitination/deubiquitination process to regulate immune checkpoint pathways

    著者: Jiaxin Liu, Yicheng Cheng, Ming Zheng, Bingxiao Yuan, Zimu Wang, Xinying Li, Jie Yin, Mingxiang Ye, Yong Song - Signal Transduction and Targeted Therapy 2021 被引用: 90

  15. Tislelizumab Plus Platinum and Etoposide Versus Placebo Plus Platinum and Etoposide as First-Line Treatment for Extensive-Stage SCLC (RATIONALE-312): A Multicenter, Double-Blind, Placebo-Controlled, Randomized, Phase 3 Clinical Trial

    著者: Ying Cheng, Yun Fan, Yanqiu Zhao, Dingzhi Huang, Xingya Li, Peng Zhang, Mafei Kang, Nong Yang, Diansheng Zhong, Zhen Wang, Yan Yu, Yu Zhang, Jun Zhao, Tai Qin, Chenqi Chen, Shiangjiin Leaw, Wenjuan Zheng, Yong Song - Journal of Thoracic Oncology 2024 被引用: 132

  16. FBW7-mediated ubiquitination and destruction of PD-1 protein primes sensitivity to anti-PD-1 immunotherapy in non-small cell lung cancer

    著者: Jiaxin Liu, Lingyun Wei, Nan Hu, Dong Wang, Juan Ni, Sha Zhang, Hongbing Liu, Tangfeng Lv, Jie Yin, Mingxiang Ye, Yong Song - Journal for ImmunoTherapy of Cancer 2022 被引用: 74

  17. Three-Dimensional Reconstruction Based on Visual SLAM of Mobile Robot in Search and Rescue Disaster Scenarios

    著者: Hongling Wang, Chengjin Zhang, Yong Song, Bao Pang, Guangyuan Zhang - Robotica 2019 被引用: 43

  18. GSDMD is required for effector CD8+ T cell responses to lung cancer cells

    著者: Guangmin Xi, Jianwei Gao, Bing Wan, Ping Zhan, Wujian Xu, Tangfeng Lv, Yong Song - International Immunopharmacology 2019 被引用: 195

  19. Metastasis-associated fibroblasts: an emerging target for metastatic cancer

    著者: Zimu Wang, Jiaxin Liu, Hairong Huang, Mingxiang Ye, Xinying Li, Ranpu Wu, Hongbing Liu, Yong Song - Biomarker Research 2021 被引用: 56

  20. The role of TWIST1 in epithelial-mesenchymal transition and cancers

    著者: Qingqing Zhu, Chenhui Ma, Qian Wang, Yong Song, Tangfeng Lv - Tumor Biology 2015 被引用: 200

  21. Low-dose carboplatin reprograms tumor immune microenvironment through STING signaling pathway and synergizes with PD-1 inhibitors in lung cancer

    著者: Zhou Li, Qiuli Xu, Litang Huang, Jiajia Jin, Xueying Zuo, Qun Zhang, Liang Ye, Suhua Zhu, Ping Zhan, Jianan Ren, Tangfeng Lv, Yong Song - Cancer Letters 2020 被引用: 119

  22. Updated Overall Survival Data and Predictive Biomarkers of Sintilimab Plus Pemetrexed and Platinum as First-Line Treatment for Locally Advanced or Metastatic Nonsquamous NSCLC in the Phase 3 ORIENT-11 Study

    著者: Yunpeng Yang, Jiya Sun, Zhehai Wang, Jian Fang, Qitao Yu, Baohui Han, Shundong Cang, Gongyan Chen, Xiaodong Mei, Zhixiong Yang, Rui Ma, Minghong Bi, Xiubao Ren, Jianying Zhou, Baolan Li, Yong Song, Jifeng Feng, Juan Li, Zhiyong He, Rui Zhou, Weimin Li, You Lü, Hui Zhou, Shuyan Wang, Luyao Sun, Óscar Puig, Christoph Mancao, Bo Peng, Wenfeng Fang, Wei Xu, Li Zhang - Journal of Thoracic Oncology 2021 被引用: 148

  23. Lipid Metabolism: Immune Regulation and Therapeutic Prospectives in Systemic Lupus Erythematosus

    著者: Wei Sun, Pengchong Li, Jianping Cai, Jie Ma, Xuan Zhang, Yong Song, Yudong Liu - Frontiers in Immunology 2022 被引用: 64

  24. Tandem CAR-T cells targeting MUC1 and PSCA combined with anti-PD-1 antibody exhibit potent preclinical activity against non-small cell lung cancer

    著者: Aying Wang, Tangfeng Lv, Yong Song - Cellular Immunology 2023 被引用: 25